When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - Expanded use of J&J's Darzalex OK'd in Europe
Genmab A/S
As expected, the European Commission approves the use of Johnson & Johnson (JNJ-0.2%) unit Janssen Biotech's Darzalex (daratumumab), combined with Celgene's Revlimid (lenalidomide) and dexamethasone, for the treatment of adults with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
More news on: Johnson & Johnson, Genmab A/S, Healthcare stocks news,